WHI-P258

CAS No. 21561-09-1

WHI-P258 ( WHI-P258; WHI-P 258; WHI-P-258; WHIP 258 )

Catalog No. M13440 CAS No. 21561-09-1

WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 In Stock
10MG 72 In Stock
25MG 140 In Stock
50MG 224 In Stock
100MG 377 In Stock
500MG 861 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WHI-P258
  • Note
    Research use only, not for human use.
  • Brief Description
    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
  • Description
    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK binding negative control in the development of new therapeutics.
  • Synonyms
    WHI-P258; WHI-P 258; WHI-P-258; WHIP 258
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; JAK3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21561-09-1
  • Formula Weight
    281.31
  • Molecular Formula
    C16H15N3O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: <1.2mg/mL
  • SMILES
    COC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC
  • Chemical Name
    6,7-Dimethoxy-N-phenylquinazolin-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
  • Dacomitinib hydrate

    Dacomitinib hydrate is a highly selective and second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor family of tyrosine kinases.

  • WHI-P258

    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.

  • (1R,2R)-Trans-N-Boc-...

    Cyclohexanediamine has a potential of anticancer activity.